Company
Relay Therapeutics
Relay Therapeutics has 4 drugs tracked on RxWires: 1 in Phase 3, 1 in Phase 2, 1 in Phase 1/2, 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Zovegalisib | Phase 3 | PIK3CA Mutation |
| RLY-2608 | Phase 2 | PIK3CA-Related Overgrowth Spectrum (PROS) |
| RLY-8161 | Phase 1/2 | Advanced NRAS-Mutant Melanoma |
| RLY-5836 | Phase 1 | PIK3CA Mutation |
Latest
- relay therapeutics filed 8-K
- Trial Completion Date Pushed 518 Days: RLY-8161
- relay therapeutics filed 8-K
- relay therapeutics filed 8-K
- relay therapeutics filed 8-K
Follow Relay Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.